| Literature DB >> 19196202 |
Bernard Metz1, Germie van den Dobbelsteen, Cécile van Els, Johan van der Gun, Lonneke Levels, Leo van der Pol, Nynke Rots, Gideon Kersten.
Abstract
The successful development of vaccines is a lengthy process, requiring input from different expertises, such as research and development, quality control, quality assurance, production, regulatory affairs, and marketing and sales. A cornerstone in vaccine development is the availability of a panel of high-quality assays that can reduce the risk of failure in clinical trials and licensure. This review highlights the quality-control issues and approaches in vaccine development from different viewpoints: discovery, process development, assay development, clinical development and the postlicensing phase.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19196202 DOI: 10.1586/14760584.8.2.227
Source DB: PubMed Journal: Expert Rev Vaccines ISSN: 1476-0584 Impact factor: 5.217